References
- Lazarski CA, Chaves FA, Jenks SA et al. The kinetic stability of MHC class II: peptide complexes is a key parameter that dictates immunodominance. Immunity23(1), 29–40 (2005).
- Mora M, Donati C, Medini D, Covacci A, Rappuoli R. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr. Opin. Microbiol.9(5), 532–536 (2006).
- Moutaftsi M, Peters B, Pasquetto V et al. A consensus epitope prediction approach identifies the breadth of murine T (CD8+)-cell responses to vaccinia virus. Nat. Biotechnol.24(7), 817–819 (2006).
- McMurry JA, Gregory SH, Moise L, Rivera D, Buus S, De Groot AS. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine DOI:10.1016/j.vaccine.2007.01. 039 (2007) (Epub ahead of print).
- Bauer T, Gunther M, Bienzle U, Neuhaus R, Jilg W. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl.13(3), 434–442 (2007).
- Pasquetto V, Bui H-H, Giannino R et al. HLA-A*0201, HLA-A*1101 and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol.175, 5504–5515 (2005).
- Kim SK, Cornberg M, Wang XZ et al. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med.201(4), 523–533 (2005).
- Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y. Schistosoma mansoni and α-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves’ hyperthyroidism. J. Immunol.173(3), 2167–2173 (2004).
- Ely LK, Green KJ, Beddoe T et al. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J. Immunol.174(9), 5593–5601 (2005).
- Wu Z, Bensinger SJ, Zhang J et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med.10(1), 87–92 (2004).
- De Groot AS, Knopf PM, Martin W. De-immunization of therapeutic proteins by T-cell epitope modification. Dev. Biol. (Basel).122, 171–194 (2005).
- Tangri S, Mothe BR, Eisenbraun J et al. Rationally engineered therapeutic proteins with reduced immunogenicity. J. Immunol.174(6), 3187–3196 (2005).
Website
- Immune Epitope Database www.immuneepitope.com